Literature DB >> 3011574

Coxsackie virus B4 produces transient diabetes in nonhuman primates.

J W Yoon, W T London, B L Curfman, R L Brown, A L Notkins.   

Abstract

Cynomolgus, rhesus, and Cebus monkeys failed to show glucose tolerance or insulin secretion abnormalities after infection with encephalomyocarditis virus or Coxsackie virus B4. Patas monkeys also showed no abnormalities after infection with encephalomyocarditis virus. However, patas monkeys infected with Coxsackie virus B4 or treated first with a subdiabetogenic dose of streptozocin and then infected sequentially with Coxsackie viruses B4 and B3 showed transient elevation of glucose tolerance tests, depressed insulin secretion, and glucose in the urine. Our experiments in nonhuman primates support earlier studies in mice and humans that under certain circumstances, Coxsackie viruses can cause abnormalities in glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011574     DOI: 10.2337/diab.35.6.712

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?

Authors:  Anne Cooke
Journal:  Immunology       Date:  2009-01       Impact factor: 7.397

2.  Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

Authors:  T M Szopa; T Ward; D M Dronfield; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

3.  Adenovirus E3 MHC inhibitory genes but not TNF/Fas apoptotic inhibitory genes expressed in beta cells prevent autoimmune diabetes.

Authors:  Marshall S Horwitz; Shimon Efrat; Urs Christen; Matthias G von Herrath; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

Review 4.  Virus infections as potential targets of preventive treatments for type 1 diabetes.

Authors:  Noora Nurminen; Sami Oikarinen; Heikki Hyöty
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

6.  Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

Authors:  J Endl; H Otto; G Jung; B Dreisbusch; F Donie; P Stahl; R Elbracht; G Schmitz; E Meinl; M Hummel; A G Ziegler; R Wank; D J Schendel
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 7.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 8.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

9.  Pathogenesis of coxsackievirus-B5 acquired from intra-renal porcine islet cell xenografts in diabetic mice.

Authors:  Suzanne E Myers; Rebecca LaRue; Daniel P Shaw; Brenda C Love; Kariuki Njenga M; Moses K Njenga
Journal:  Xenotransplantation       Date:  2009 Mar-Apr       Impact factor: 3.907

10.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.